Cargando…
Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions
Ebola virus is responsible for causing severe hemorrhagic fevers, with case fatality rates of up to 90%. Currently, no antiviral or vaccine is licensed against Ebola virus. A phosphatidylserine-targeting antibody (PGN401, bavituximab) has previously been shown to have broad-spectrum antiviral activi...
Autores principales: | Dowall, S. D., Graham, V. A., Corbin-Lickfett, K., Empig, C., Schlunegger, K., Bruce, C. B., Easterbrook, L., Hewson, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359806/ https://www.ncbi.nlm.nih.gov/pubmed/25815346 http://dx.doi.org/10.1155/2015/347903 |
Ejemplares similares
-
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity
por: Dowall, Stuart D, et al.
Publicado: (2014) -
Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product
por: Dowall, Stuart D., et al.
Publicado: (2017) -
Proteomic analysis of purified turkey adenovirus 3 virions
por: Kumar, Pankaj, et al.
Publicado: (2015) -
TIM-family Proteins Promote Infection of Multiple Enveloped Viruses through Virion-associated Phosphatidylserine
por: Jemielity, Stephanie, et al.
Publicado: (2013) -
Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic
por: Dowall, Stuart D., et al.
Publicado: (2016)